ANNA MANDALAKAS to Cost-Benefit Analysis
This is a "connection" page, showing publications ANNA MANDALAKAS has written about Cost-Benefit Analysis.
Connection Strength
0.243
-
Key actors' perspectives on cost-effectiveness analysis in Uganda: a cross-sectional survey. BMC Health Serv Res. 2014 Nov 04; 14:539.
Score: 0.092
-
Modelling the cost-effectiveness of strategies to prevent tuberculosis in child contacts in a high-burden setting. Thorax. 2013 Mar; 68(3):247-55.
Score: 0.078
-
Is screening immigrants for latent tuberculosis cost-effective? Lancet Infect Dis. 2011 Jun; 11(6):418-9.
Score: 0.073